Genitourinary Cancer Trial

Prostate, Hormone-Sensitive

Abiraterone Acetate and Antiandrogen Therapy with or without Cabazitaxel and Prednisone in Treating Patients with Metastatic, Castration-Resistant Prostate Cancer Previously Treated with Docetaxel

OR

Cabazitaxel with Abiraterone versus Abiraterone alone Randomized Trial for
Extensive Disease following Docetaxel: The CHAARTED2 Trial

 

National Cancer Institute: Trial record on cancer.gov

ClinicalTrials.gov ID: NCT03419234

Return to Home Page | Review Other Active Trials